The pharmaceutical industry is aggressively evolving, with increasing demand for high-performance Active Pharmaceutical Ingredients (APIs). Dulaglutide, a diabetes drug, stands as example of this trend. To meet this demand, US-based manufacturing services are stepping forward. These companies offer a detailed suite of capabilities, from research an